Hirofumi Ishii
Astellas Pharma (Japan)(JP)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Glycosylation and Glycoproteins Research, Protease and Inhibitor Mechanisms, Diabetes, Cardiovascular Risks, and Lipoproteins, Thyroid Cancer Diagnosis and Treatment
Most-Cited Works
- → Human Apolipoprotein E Receptor 2(1996)385 cited
- → cDNA Cloning of a New Low-Density Lipoprotein Receptor-Related Protein and Mapping of Its Gene (LRP3) to Chromosome Bands 19q12–q13.2(1998)47 cited
- → Impacts of NRF2 activation in non–small‐cell lung cancer cell lines on extracellular metabolites(2019)39 cited
- → Renal Cell Carcinoma of the Native Kidney after Renal Transplantation(1991)30 cited
- → Increased Patchy Renal Accumulation of <sup>99m</sup>Tc-Methylene Diphosphonate in a Patient with Severe Loin Pain after Exercise(1987)13 cited
- → Discovery and Biological Evaluation of Potent and Orally Active Human 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors for the Treatment of Type 2 Diabetes Mellitus(2019)5 cited
- → Combination chemotherapy for multiple myeloma with melphalan, ifosfamide, prednisolone, nitrosourea and vincristine.(1988)1 cited
- → Blood pressure changes and renal transplantation(1988)
- → Studies on 10 cases of thyroid tumor associated with secondary hyperparathyroidism.(1996)
- [Dynamic computed tomography (CT) in the rat kidney and application to acute renal failure models].(1995)